Prognosis of papillary thyroid cancer in patients with Graves’ disease: a propensity score-matched analysis

[1]  A. Cecchini,et al.  Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinical outcomes. , 2020, Pathology, research and practice.

[2]  G. Barbesino,et al.  Graves’ disease , 2020, Nature Reviews Disease Primers.

[3]  A. Uysal,et al.  Frequency of thyroid nodules and thyroid cancer in thyroidectomized patients with Graves’ disease , 2019, Archives of medical science : AMS.

[4]  A. Antonelli,et al.  Thyroid autoimmune disorders and cancer. , 2020, Seminars in cancer biology.

[5]  M. Rotondi,et al.  Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study , 2020, Journal of endocrinological investigation.

[6]  M. Hier,et al.  Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves’ disease patients: a retrospective matched cohort study , 2019, Journal of Otolaryngology - Head & Neck Surgery.

[7]  E. Erdas,et al.  Predictive Factors of Recurrence in Patients with Differentiated Thyroid Carcinoma: A Retrospective Analysis on 579 Patients , 2019, Cancers.

[8]  P. Rattanawong,et al.  PROGNOSIS OF DIFFERENTIATED THYROID CARCINOMA IN PATIENTS WITH GRAVES' DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. , 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[9]  R. Menon,et al.  The Outcome of Papillary Thyroid Cancer Associated with Graves' Disease: A Case Control Study , 2018, Journal of thyroid research.

[10]  M. Tuveri,et al.  Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies , 2018, Journal of Otolaryngology - Head & Neck Surgery.

[11]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[12]  Фадеев Валентин Викторович,et al.  Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. , 2017 .

[13]  S. Rivkees,et al.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. , 2016, Thyroid : official journal of the American Thyroid Association.

[14]  G. Eslick,et al.  Thyroid carcinoma in Graves' disease: A meta-analysis. , 2016, International journal of surgery.

[15]  A. Miyauchi,et al.  Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease. , 2016, Endocrine journal.

[16]  Terry J. Smith,et al.  Graves' Disease. , 2016, The New England journal of medicine.

[17]  Yong Joon Suh,et al.  Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients , 2015, Annals of Surgical Oncology.

[18]  K. Guo,et al.  Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis. , 2014, International journal of clinical and experimental pathology.

[19]  Yen-Kung Chen,et al.  Cancer risk in patients with Graves' disease: a nationwide cohort study. , 2013, Thyroid : official journal of the American Thyroid Association.

[20]  L. Hegedüs,et al.  Morbidity before and after the Diagnosis of Hyperthyroidism: A Nationwide Register-Based Study , 2013, PloS one.

[21]  A. Belfiore,et al.  Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease. , 2013, The Journal of clinical endocrinology and metabolism.

[22]  S. Mandel,et al.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. , 2012, Thyroid : official journal of the American Thyroid Association.

[23]  R. Paschke,et al.  Thyroid Cancer in Patients with Hyperthyroidism , 2012, Hormone and Metabolic Research.

[24]  K. Hemminki,et al.  Cancer risk in patients hospitalised for Graves’ disease: a population-based cohort study in Sweden , 2010, British Journal of Cancer.

[25]  R. Latif,et al.  Characterization of thyrotropin receptor antibody-induced signaling cascades. , 2009, Endocrinology.

[26]  C. Park,et al.  Clinicopathologic Features and Treatment Outcomes in Differentiated Thyroid Carcinoma Patients with Concurrent Graves' Disease , 2008, Journal of Korean medical science.

[27]  Yukiko Yano,et al.  Recent outcome of Graves' disease patients with papillary thyroid cancer. , 2007, European journal of endocrinology.

[28]  B. Lang,et al.  Staging Systems for Papillary Thyroid Carcinoma: A Review and Comparison , 2007, Annals of surgery.

[29]  L. Wartofsky,et al.  Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.

[30]  H. Yamashita,et al.  Prognosis of small thyroid cancer in patients with Graves' disease , 2006, The British journal of surgery.

[31]  C. Solórzano,et al.  Thyroidectomy remains an effective treatment option for Graves' disease. , 2006, American journal of surgery.

[32]  M. Castellano,et al.  Outcome of Patients Surgically Treated for Various Forms of Hyperthyroidism with Differentiated Thyroid Cancer: Experience at an Endocrine Center in Italy , 2005, Surgery Today.

[33]  Tae Yong Kim,et al.  Ultrasonographic screening for detection of thyroid cancer in patients with Graves’ disease , 2004, Clinical endocrinology.

[34]  Ling-Feng Wang,et al.  Prevalence of Thyroid Cancer in Hyperthyroidism Treated by Surgery , 2003, The Kaohsiung journal of medical sciences.

[35]  A. Cavallaro,et al.  Thyroid Cancer in Patients with Hyperthyroidism , 2003, Hormone Research in Paediatrics.